Educational Materials

The Study

Study design and patient characteristics of the KEYNOTE-177 study
Main results of the KEYNOTE-177 study
Adverse events and quality of life data in the KEYNOTE-177 study
Professor Eric Van Cutsem, MD, PhD (UZ Leuven) and Professor Karen Geboes, MD, PhD (UZ Ghent) discuss the KEYNOTE-177 study
Prof. Dr. Van den Eynde (UCL Brussels)

Adverse Event Management

Prof. Dr. Marc Peeters (UZA) talks about the immune-related adverse event management at Belgian Week of Gastroenterology 2021

Professor Van den Eynde, MD, PhD (Cliniques Universitaires Saint-Luc) talks about the management of immune related adverse events with immunotherapy

Professor Eric Van Cutsem, MD, PhD (UZ Leuven) and Professor Van den Eynde, MD, PhD (Cliniques Universitaires Saint-Luc) discuss the adverse event management with immunotherapy and its impact for the patients

CRC: Colorectal cancer; dMMR: Mismatch Repair deficient; mCRC: metastatic CRC; MSI-h: Microsatellite Instability High

Please consult the prescribing information before prescribing.